Cargando…
Evolution of Antibiotic Tolerance During Oxacillin, Daptomycin and Dalbavancin Therapy Results in Breakthrough Staphylococcus aureus Bacteremias
BACKGROUND: Clinicians can employ suppressive antimicrobial therapy in patients with persistent or relapsing bacteremia. However, bacteria with favorable susceptibility profiles may exhibit antimicrobial tolerance wherein bacteria cannot proliferate yet can survive in high concentrations of antibiot...
Autores principales: | Berti, Andrew, Schroeder, Jeremy, Rottier, Aaron, McCrone, Sue, Wang, Jade, Rose, Warren |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631970/ http://dx.doi.org/10.1093/ofid/ofx162.033 |
Ejemplares similares
-
Dalbavancin for Staphylococcus aureus Bacteremia: Are We There Yet?
por: Mahatanan, Rattanaporn, et al.
Publicado: (2023) -
307. Rapid Resistance Development to Three Antistaphylococcal Therapies in Daptomycin-tolerant Staphylococcus aureus Bacteremia
por: Miller, Christopher R, et al.
Publicado: (2020) -
2403. Comparison of Daptomycin Combination Therapy With Ceftaroline or Oxacillin Against Methicillin-Resistant Staphylococcus aureus (MRSA) Isolates Causing Persistent Bacteremia
por: Bouchard, Jeannette, et al.
Publicado: (2018) -
117. Adjunctive Daptomycin in the Treatment of staphylococcus Aureus Bacteremia
por: Cheng, Matthew P, et al.
Publicado: (2020) -
Outcomes in Patients with Staphylococcus aureus Bacteremia Treated with Dalbavancin in Clinical Trials
por: Gonzalez, Pedro L., et al.
Publicado: (2021)